Bullish case
$44 to $52
More likely if Q2 2026 record inflow momentum persists, QQQ and ETF economics lift net revenue yield, adjusted operating margin stays near 37.5%, leverage stays low, and the market assigns IVZ a 12x to 13x earnings multiple.
Invesco Ltd. research snapshot
IVZ AI stock analysis currently reads Invesco as a cyclical asset manager in a clearly improving phase rather than a simple compounder. The company reported Q2 2026 adjusted diluted EPS of $0.71, record net long-term inflows of $45.1 billion, and ending AUM of $2.47 trillion as of June 30, 2026, with adjusted operating margin expanding to 37.5% and net debt falling to $708.6 million. The scenario forecast is positive but not extreme: strong flows, QQQ economics, and margin expansion support the bull case, while fee pressure, market beta, leverage, preferred stock, and active product outflows keep investment certainty moderate. This page is for informational research only and is not investment advice.
Current price
$29.60
Market cap
$13.07 billion verified by price times Q2 2026 shares
AI score
67 / 100
Rating
Improving asset manager with record flows, deleveraging, and a still reasonable valuation
Trend status
Constructive uptrend, price above the 50-day and 200-day moving averages after a Q2 2026 earnings beat
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Invesco earns fees from ETFs, active equity, fixed income, alternatives, money market, model portfolios, and institutional mandates, with revenue tied to AUM levels and product mix. | Medium-high |
| Moat | The moat is strongest in QQQ, ETF distribution, global platform breadth, fixed income capability, and advisor relationships, but weaker in commoditized active products. | Medium |
| Management | Andrew Schlossberg has executed simplification, QQQ conversion to an open-end fund ETF, private markets partnerships, net debt reduction of more than $450 million in Q2 2026, and a return to buybacks. | Medium-high |
| Financial trend | Q2 2026 operating revenue was $1.826 billion, adjusted EPS was $0.71, ending AUM was $2.47 trillion, adjusted operating margin was 37.5%, and net debt fell to $708.6 million. | High |
| Valuation | At $29.60 and forward EPS near $3.01 implied by the 9.85x forward PE, IVZ screens at roughly 9.85x forward earnings, 1.05x book value, and a 14.73% free cash flow yield using StockAnalysis per-share data. | Medium |
| Technical trend | The tape is constructive: IVZ closed at $29.60 on July 31, 2026, above the 20-day, 50-day, 100-day, and 200-day moving averages, with 14-day RSI near 54.75. | Medium-high |
| Risk level | Main risks are market drawdowns, outflows, fee compression, debt and preferred stock burden, active manager underperformance, regulation, and expense inflation. | Medium-high |
| AI confidence | Descriptive confidence is high because filings and market data are available. Forecast confidence is lower because IVZ is highly sensitive to markets and flows. | High data confidence |
| Investment certainty | The stock can work if AUM, QQQ revenue, margins, and capital returns keep improving, and the Q2 2026 record is supportive, but IVZ is still not a high certainty compounder at any price. | Medium-low |
IVZ AI stock forecast
The IVZ AI stock forecast uses scenario math around the $29.60 July 31, 2026 price reference, forward EPS near $3.01 implied by the 9.85x forward PE, and a three-year earnings multiple framework. The audited model produced a bearish area near $24.70, a base area near $38.30, and a bullish area near $52.10 before dividends.
$44 to $52
More likely if Q2 2026 record inflow momentum persists, QQQ and ETF economics lift net revenue yield, adjusted operating margin stays near 37.5%, leverage stays low, and the market assigns IVZ a 12x to 13x earnings multiple.
$33 to $40
More likely if adjusted EPS grows modestly, AUM stays near current levels, buybacks continue to offset dilution, fee pressure remains manageable, and IVZ trades near a 10x to 11x earnings multiple.
$22 to $27
More likely if markets weaken, net flows reverse, QQQ revenue benefit disappoints, adjusted margins compress, or investors discount adjusted earnings more heavily after the record growth period.
IVZ AI technical analysis
IVZ AI technical analysis is constructive as of the August 2, 2026 cutoff. StockAnalysis showed IVZ at $29.60 at the July 31, 2026 close, up 37.80% over 52 weeks. Barchart listed the 5-day moving average at $29.33, 20-day at $29.19, 50-day at $28.20, 100-day at $26.59, and 200-day at $26.14, with 14-day relative strength near 54.75 and 14-day ADX near 20.67 with +DI above -DI.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $29.60 | StockAnalysis July 31, 2026 market close used for the price reference. |
| Immediate support | $29.19 | Barchart lists the 20-day moving average near $29.19, and the 5-day average sits near $29.33, forming a short-term support cluster. |
| 50-day moving average | $28.20 | Both Barchart and StockAnalysis place the 50-day average near $28.20, a useful short to medium-term trend marker. |
| 200-day moving average | $26.14 | Both feeds agree on the 200-day average near $26.14, now clearly below price, which supports the longer-term uptrend. |
| Near resistance | $30.00 to $31.02 | StockAnalysis lists the 52-week high near $31.02. A sustained move through that area would confirm stronger demand. |
| Momentum | RSI near 54.75 | Barchart shows neutral to mildly bullish momentum rather than an overbought extreme, with ADX near 20.67 and +DI above -DI. |
| Volume and volatility | Average volume near 5.0 million, 14-day ATR near $1.00 | Barchart shows active liquidity, roughly 3.4% two-week average true range as a percent of price, and 14-day historic volatility near 40.9%. |
| Invalidation | Close below $28.20 | A close below the 50-day moving average would weaken the recovery setup and shift focus to the 100-day and 200-day averages near $26.59 and $26.14. |
IVZ AI trading strategy
The IVZ AI trading strategy below is a rules-based research framework, not personalized advice. It combines market regime, AUM trend, fund flows, QQQ economics, capital return, deleveraging, and technical confirmation.
Watch for IVZ to hold above the $29.19 to $29.33 cluster and then clear $30.00 to $31.02 with continued record net long-term inflows, positive AUM releases, margin expansion, and stable expense guidance.
A failed breakout back below the 20-day average or a close below $28.20 should reduce setup confidence.
If IVZ pulls back toward $28.20 to $29.19 without a new market drawdown or flow shock, compare price behavior with AUM releases, ETF demand, fixed income flows, and credit spreads.
Do not average down if broad markets are falling, active outflows accelerate, or debt and preferred capital concerns return.
Track monthly AUM, net long-term flows, QQQ revenue contribution, adjusted operating margin, net debt, cash, preferred stock balance, buybacks, dividend coverage, and active fund performance.
Position sizing should reflect that IVZ is partly a levered expression of markets, flows, and investor appetite for asset manager equities.
Investment research summary
Invesco sells investment access, portfolio management, ETF exposure, active strategies, fixed income products, alternatives, and institutional solutions. Clients pay for distribution, product choice, brand trust, and investment process.
The moat is narrow to moderate overall. QQQ and ETF distribution have stronger brand and scale advantages, while many active strategies face substitutable products, fee pressure, and performance-sensitive flows.
The thesis fails if markets fall, clients redeem, active performance disappoints, fee rates keep compressing, QQQ benefits are offset by costs, or debt and preferred stock limit capital returns after the recent deleveraging.
Andrew Schlossberg has delivered on focus, scale, balance sheet repair, QQQ modernization, record inflows, and margin expansion. The execution test is whether those moves convert higher AUM into durable per-share earnings through market cycles.
Asset management benefits from retirement savings, ETF adoption, model portfolios, alternatives, and global wealth growth. The offset is that passive products pressure fees and weak markets can reverse AUM quickly.
IVZ screens inexpensive on forward earnings, book value, dividend yield, and FCF yield, but that valuation still partly reflects cyclicality, impairment history, leverage, and lower confidence in normalized earnings.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| IVZ price reference | $29.60 at July 31, 2026 close | StockAnalysis | August 2, 2026 |
| Market capitalization | $13.07 billion calculated from $29.60 price and 441.5 million Q2 2026 shares | Pineify financial_rigor.py using Invesco Q2 2026 share count | August 2, 2026 |
| Q2 2026 operating revenues | $1,825.6 million | Invesco Q2 2026 Results | August 2, 2026 |
| Q2 2026 adjusted diluted EPS | $0.71, up 24.6% quarter over quarter and 97.2% year over year | Invesco Q2 2026 Results | August 2, 2026 |
| Q2 2026 ending AUM | $2,470.3 billion, up 14.4% from Q1 2026 | Invesco Q2 2026 Results | August 2, 2026 |
| Q2 2026 adjusted operating margin | 37.5%, up 3 percentage points quarter over quarter | Invesco Q2 2026 Results | August 2, 2026 |
| Q2 2026 net long-term inflows | $45.1 billion, a quarterly record | Invesco Q2 2026 Results | August 2, 2026 |
| Q2 2026 cash, debt, and net debt | $915.4 million cash, $1,624.0 million debt, $708.6 million net debt | Invesco Q2 2026 Results | August 2, 2026 |
| Q2 2026 common shares outstanding | 441.5 million | Invesco Q2 2026 Results | August 2, 2026 |
| June 30, 2026 preliminary AUM | $2,470.3 billion | Invesco Corporate AUM release | August 2, 2026 |
| Valuation ratios | Forward PE 9.85, PB 1.05, P/FCF 6.79, FCF yield 14.73%, dividend yield 2.91% | StockAnalysis statistics | August 2, 2026 |
| Per-share valuation inputs | BVPS $28.25, FCF per share $4.36, dividend per share $0.86 | StockAnalysis statistics | August 2, 2026 |
| Technical indicators | RSI 54.75, 50-day MA $28.20, 200-day MA $26.14, 52-week change +37.80% | StockAnalysis statistics and Barchart | August 2, 2026 |
| Moving averages and ATR | 5-day MA $29.33, 20-day MA $29.19, 50-day MA $28.20, 100-day MA $26.59, 200-day MA $26.14, 14-day ATR $1.00 | Barchart | August 2, 2026 |
This IVZ AI stock analysis is an informational research tool, not investment advice, a recommendation, or a guarantee of future returns. Forecast scenarios are based on available public data as of August 2, 2026 and may be wrong if markets, AUM, flows, fees, earnings, leverage, or valuation multiples change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.